| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $17.7B | $17.2B | $14.8B | $13.7B | $12.1B | $11.4B | $2.9B |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | $1.7B | $1.6B | $1.3B | $1.2B | $1.0B | $1.0B | $0.9B |
| Operating Income | $1.9B | $4.1B | $2.7B | $-1.2B | $-1.5B | $1.5B | $0.3B |
| Net Income | $0.9B | $2.7B | $1.5B | $-1.2B | $-1.3B | $0.6B | $0.2B |
| EPS (Basic) | $2.22 | $7.16 | $3.63 | $-3.26 | $-2.69 | $1.30 | $0.49 |
| EPS (Diluted) | $2.18 | $7.00 | $3.58 | $-3.26 | $-2.69 | $1.30 | $0.49 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $41.5B | $37.8B | $33.0B | $32.8B | $29.7B | $25.2B | $26.6B |
| Current Assets | $9.2B | $8.1B | $11.6B | $11.1B | $7.9B | $3.4B | $4.1B |
| Cash & Equivalents | $0.8B | $1.2B | $3.5B | $0.5B | $1.3B | $0.4B | $0.3B |
| Total Liabilities | $36.4B | $32.2B | $27.6B | $27.9B | $21.4B | $16.8B | $18.7B |
| Current Liabilities | $11.8B | $8.4B | $9.8B | $10.3B | $5.8B | $3.0B | $4.6B |
| Stockholders' Equity | $5.1B | $5.6B | $5.3B | $4.9B | $8.3B | $8.4B | $8.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.1B | $4.6B | $5.5B | $0.5B | $-0.2B | $3.3B | $2.7B |
| Investing Cash Flow | $-4.4B | $-5.3B | $-2.1B | $-1.2B | $-1.2B | $-1.6B | $-1.7B |
| Capital Expenditures | $2.8B | $2.1B | $1.7B | $1.3B | $1.0B | $1.3B | $0.5B |
| Financing Cash Flow | $-0.1B | $-1.6B | $-0.3B | $-0.1B | $2.3B | $-1.8B | $-1.2B |